Drug-resistant tuberculosis treatments, the case for a phase III platform trial - Yates, Tom A.
Bulletin of the World Health Organization 2024 102(9) 657-664
Keywords: Antitubercular Agents -- therapeutic use; Clinical Trials, Phase III as Topic; Diarylquinolines; Tuberculosis, Multidrug-Resistant -- drug therapy